Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 3/20 | 0.55 |
| ▸ | MAOB | P27338 | 3/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | MTOR | P42345 | 4/20 | 0.51 |
| ▸ | OGG1 | O15527 | 2/20 | 0.50 |
| ▸ | NPC1 | O15118 | 4/20 | 0.48 |
| ▸ | RAB9A | P51151 | 4/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 4/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | CCR6 | P51684 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4882302 | 1.00 | MAOA (0.55) | MAOAMAOBCYP1A2CYP3A4CYP2C19 | |
| SCHEMBL4882768 | 0.91 | LMNA (0.52) | CYP1A2CYP3A4CYP2C19MTOROGG1 | |
| SCHEMBL4882773 | 0.91 | LMNA (0.52) | CYP1A2CYP3A4CYP2C19MTOROGG1 | |
| SCHEMBL4888888 | 0.88 | CYP1A2 (0.64) | CYP1A2CYP3A4CYP2C19MTOROGG1 | |
| SCHEMBL4888895 | 0.88 | CYP1A2 (0.64) | CYP1A2CYP3A4CYP2C19MTOROGG1 | |
| SCHEMBL4886315 | 0.88 | MAPT (0.58) | CYP1A2CYP3A4CYP2C19MTOROGG1 | |
| SCHEMBL4886333 | 0.88 | MAPT (0.58) | CYP1A2CYP3A4CYP2C19MTOROGG1 | |
| SCHEMBL4878014 | 0.87 | NPC1 (0.59) | CYP1A2CYP3A4CYP2C19MTOROGG1 | |
| SCHEMBL4878016 | 0.87 | NPC1 (0.59) | CYP1A2CYP3A4CYP2C19MTOROGG1 | |
| SCHEMBL4882658 | 0.86 | RAB9A (0.62) | MAOAMAOBCYP1A2NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080227787-A1 | Use of New Lipoxygenase Inhibitors | BIOLIPOX AB (SE) | 2008-09-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080227787-A1 | Use of New Lipoxygenase Inhibitors | ALOX15, ALOX15B, ALOX12 | MAOA 163/4885MAOB 125/4885CYP1A2 74/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.